Blend Labs, Inc. <BLND.N>: Wells Fargo Cuts Target Price to $3 From $4
BLND•Related News
Soligenix Q2 net loss narrows as R&D expenses fall
SNGX•
Baker Hughes Company <BKR.O>: Morgan Stanley resumes coverage with overweight rating; price target $70
BKR•
Take-Two sticks to annual bookings outlook, says on track for 'GTA VI' November launch
TTWO•
Faeth Therapeutics presents PK/PD modeling supporting PIKTOR dose in Phase 2 endometrial cancer trial FTH-PIK-201
FTH•
Microchip Technology <MCHP.O>: Truist Securities cuts target price to $90 from $105
MCHP•